Aigen Investment Management’s Innoviva INVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-14,980
Closed -$299K 648
2025
Q4
$299K Sell
14,980
-294
-2% -$5.74K 0.07% 360
2025
Q3
$279K Sell
15,274
-12,729
-45% -$248K 0.04% 563
2025
Q2
$563K Sell
28,003
-12,807
-31% -$246K 0.08% 371
2025
Q1
$740K Buy
+40,810
New +$732K 0.12% 264
2023
Q2
Sell
-32,036
Closed -$360K 864
2023
Q1
$360K Sell
32,036
-15,693
-33% -$190K 0.05% 385
2022
Q4
$632K Buy
+47,729
New +$627K 0.09% 225
2020
Q3
Sell
-36,817
Closed -$515K 978
2020
Q2
$515K Buy
36,817
+33,672
+1,071% +$458K 0.07% 448
2020
Q1
$37K Buy
+3,145
New +$41.6K ﹤0.01% 1028

Other funds holding INVA

Aigen Investment Management's INVA Position: Q1 2026 in Review

Aigen Investment Management sold out of Innoviva (INVA) in Q1 2026, closing a stake of 14,980 shares — an estimated $299K sold.

Aigen Investment Management first reported a position in INVA in Q1 2020 and held it in 8 quarters. The position peaked at $740K in Q1 2025. 286 funds tracked by Wall St. Rank hold INVA as of Q1 2026.

  • Aigen Investment Management reported no remaining Innoviva position as of Q1 2026 after selling out during the quarter.
  • Aigen Investment Management sold 14,980 Innoviva shares in Q1 2026, an estimated $299K.
  • Aigen Investment Management first reported a position in Innoviva in Q1 2020 and held it in 8 quarters.
  • Aigen Investment Management's Innoviva position peaked at $740K in Q1 2025.
  • 286 funds tracked by Wall St. Rank held Innoviva as of Q1 2026.

Based on Aigen Investment Management's 13F filing for Q1 2026, filed 15 May 2026.